Showing results (181-190 of 220) with videos related to
Sort By:
Pageof 22
Frontiers in Plant Science|April 28, 2022
Maize Leaf Appearance Rates: A Synthesis From the United States Corn BeltCaio L Dos Santos, Lori J Abendroth, Jeffrey A Coulter, et al.Pharmacogenetics|November 24, 1998
Quantification of intraindividual variability and the influence of menstrual cycle phase on CYP2D6 activity as measured by dextromethorphan phenotypingA D Kashuba, A N Nafziger, G L Kearns, et al.Clinical Pharmacology and Therapeutics|December 1, 1999
Dose dependency of dextromethorphan for cytochrome P450 2D6 (CYP2D6) phenotypingD S Streetman, R E Ellis, A N Nafziger, et al.Resuscitation|April 20, 2010
Knowledge translation in emergency medical services: a qualitative survey of barriers to guideline implementationBlair L Bigham, Tom P Aufderheide, Daniel P Davis, et al.Metabolic Syndrome and Related Disorders|March 29, 2008
An evaluation of the atkins' dietBernard V Miller, Joseph S Bertino, Roberta G Reed, et al.Journal of Imaging|July 25, 2022
Quantification of Sub-Pixel Dynamics in High-Speed Neutron ImagingMartin L Wissink, Todd J Toops, Derek A Splitter, et al.Journal of Clinical Pharmacology|May 18, 2004
Limited sampling strategy of S-warfarin concentrations, but not warfarin S/R ratios, accurately predicts S-warfarin AUC during baseline and inhibition in CYP2C9 extensive metabolizersJoseph D Ma, Anne N Nafziger, Angela D M Kashuba, et al.Clinical Pharmacology and Therapeutics|November 4, 2000
Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail"D S Streetman, J F Bleakley, J S Kim, et al.Clinical Pharmacology and Therapeutics|October 3, 1998
Effect of fluvoxamine therapy on the activities of CYP1A2, CYP2D6, and CYP3A as determined by phenotypingA D Kashuba, A N Nafziger, G L Kearns, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 9, 2020
Decreasing High-risk Exposures for Healthcare Workers Through Universal Masking and Universal Severe Acute Respiratory Syndrome Coronavirus 2 Testing on Entry to a Tertiary Care FacilityJeremey Walker, Molly E Fleece, Russell L Griffin, et al.Pageof 22